EGFR-Directed Therapy in Lung Cancer

Cambridge University Press
SKU:
9781009342308
|
UPC:
9781009342308
£17.78
(No reviews yet)
Condition:
New
Current Stock:
Adding to cart… The item has been added
This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.


  • | : So Yeon Kim (Yale School of Medicine, Connecticut), Daniel B. Costa (Harvard Medical School, Massachusetts), Daisuke Shibahara (Harvard Medical School, Massachusetts), Susumu Kobayashi (Harvard Medical School, Massachusetts), Balazs Halmos (Albert Einstein College of Medicine, New York)
  • | Publisher: Cambridge University Press
  • | Publication Date: Jan 26, 2023
  • | Country of Publication: United Kingdom
  • | Number of Pages: 75 pages
  • | Language: Unknown
  • | Binding: Paperback / softback
  • | ISBN-10: 1009342304
  • | ISBN-13: 9781009342308
By (Author):
So Yeon Kim (Yale School of Medicine, Connecticut), Daniel B. Costa (Harvard Medical School, Massachusetts), Daisuke Shibahara (Harvard Medical School, Massachusetts), Susumu Kobayashi (Harvard Medical School, Massachusetts), Balazs Halmos (Albert Ei
Publisher:
Cambridge University Press
Publication Date:
Jan 26, 2023
Country of Publication:
United Kingdom
Language:
Unknown
Number of pages:
75 pages
Binding:
Paperback / softback
ISBN-10:
1009342304
ISBN-13:
9781009342308